In Defense of 50:50 Randomization
I’ve been in meetings where “adaptive” was treated as a synonym for “smaller trial.” The assumption goes like this: if we can learn as we go, we can stop early when something works, drop arms that fail, and route patients to better treatments. Surely that means fewer patients overall.